CD34+ expansion media composition:
Components | From | Stock Conc. | Working Conc. |
StemSpan™ SFEM II | STEMCELL Technologies | | |
SCF | Peprotech | (100ng/µl) | (240ng/ml) |
FLT3 | Peprotech | (100ng/µl) | (240ng/ml) |
IL6 | Peprotech | (100ng/µl) | (40ng/ml) |
TPO | Peprotech | (50ng/µl) | (75ng/ml) |
Pen/Strep | Gibco | (100X) | (1X) |
- Once the CD34+ cells are isolated from the PBMNCs, the cells can be resuspended in the expansion media (day 0).
- Seeding density: 0.5–0.7 × 106 cells/ml.
- On day 2 of expansion perform base editing and maintain the cells in the expansion media till day 6, with a media change on day 4.
- Base editing is carried out with 1 million CD34+ cells + 100pm synthego gRNA + 5µg of ABE 8e mRNA.
- Seeding density after editing: 0.5 × 106 cells/ml.
- On day 6 we can set for erythroid differentiation
CD34+ erythroid differentiation media:
Components | From | Stock Conc. | Working Conc. |
IMDM glutamax | Gibco | | |
AB serum | MP | | 5% |
Insulin (5ml) | Sigma | 9.5-11.5 mg/mL | 1ml/1000ml |
Heparin 100U/mg | Sigma | 1200U/ml | 2U/ml |
EPO | Zyrop | (2U/µl) | (3U/µl) |
Holo-Transferrin | BB sol | 330mg/ml | 330µg/ml |
SCF | Peprotech | 100ng/µl | 100ng/ml |
IL3 | Peprotech | 5ng/µl | 2.5ng/ml |
Pen/Strep | Gibco | (100X) | (1X) |
Hydrocortisone | Sigma | | 1µM |
- The composition given above is for Phase 1 media (media change on day 0 and day 3).
- Without IL3 and hydrocortisone is Phase 2 media (media change on day 6 and day 9).
- Without IL3, SCF and hydrocortisone is Phase 3 media (media change on day 12, 15 and 18).
- Seeding density: 0.8× 106 cells/ml.
- We start differentiation in 65mm dish (Day0) and then change to 10cm dish during differentiation (day 3, 6, 9, 12, 15, 18).